Interestingly, PECAM1 staining revealed a significantly diminished microvascular density (MVD) in RPMI-8226 tumor masses from macitentan-treated mice, as compared to controls (Figure 2D), thus suggesting that in MM macitentan could also exert an anti-angiogenic activity. This evidence concerns the gene PECAM1 and Miyoshi myopathy.